the Safety and Efficacy Evaluation of HGI-002 Injection in Patients With Transfusion-Dependent α-Thalassemia
Clinical trial NCT05851105 · RECRUITING
Trial details
- NCT number
- NCT05851105
- Sponsor
- Shenzhen Hemogen
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-08
- Primary completion
- 2026-12-30
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.